Clinical Trial Update: Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports results for busulfan and clofarabine conditioning followed by allogeneic stem cell transplantation in patients with a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• BUSULFAN (Busulfan)
• Clofarabine (clofarabine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2017-07-13